| scholarly article | Q13442814 |
| P356 | DOI | 10.3390/NU9050485 |
| P8608 | Fatcat ID | release_735hm5yb2vh27g7qvzam66ugnu |
| P932 | PMC publication ID | 5452215 |
| P698 | PubMed publication ID | 28492501 |
| P50 | author | Jacopo Troisi | Q64515395 |
| Pietro Campiglia | Q51446412 | ||
| P2093 | author name string | Pietro Vajro | |
| Luca Pierri | |||
| Antonella Bisogno | |||
| Francesca Marciano | |||
| Salvatore Guercio Nuzio | |||
| Annamaria Landolfi | |||
| Carmen Palladino | |||
| Federica Belmonte | |||
| P2860 | cites work | Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of Metabolomics | Q26753047 |
| Interplay between lipids and branched-chain amino acids in development of insulin resistance | Q26852310 | ||
| Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions | Q27028844 | ||
| Food, youth and the Mediterranean diet in Spain. Development of KIDMED, Mediterranean Diet Quality Index in children and adolescents | Q59353507 | ||
| p-Cresol sulfate is the dominant component of urinary myelin basic protein like material | Q73699320 | ||
| Childhood Obesity, Breastfeeding, Intestinal Microbiota, and Early Exposure to Antibiotics: What Is the Link? | Q87651500 | ||
| Serum aminotransferases in nonalcoholic fatty liver disease are a signature of liver metabolic perturbations at the amino acid and Krebs cycle level | Q38801309 | ||
| Induction of the Keap1/Nrf2/ARE pathway by oxidizable diphenols | Q39655148 | ||
| Intensive lifestyle treatment for non-alcoholic fatty liver disease in children with severe obesity: inpatient versus ambulatory treatment | Q40598412 | ||
| Urinary (1)H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment. | Q41158897 | ||
| Effects of xylitol on metabolic parameters and visceral fat accumulation | Q42783668 | ||
| Metabolic, hormonal, oxidative, and inflammatory factors in pediatric obesity-related liver disease | Q46607126 | ||
| Noninvasive markers of oxidative DNA stress, RNA degradation and protein degradation are differentially correlated with resting metabolic rate and energy intake in children and adolescents | Q46626482 | ||
| Emerging pathomechanisms involved in obesity | Q48031675 | ||
| Percentile reference values for anthropometric body composition indices in European children from the IDEFICS study | Q49046598 | ||
| High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis. | Q51453492 | ||
| Multiple gut-liver axis abnormalities in children with obesity with and without hepatic involvement. | Q51500710 | ||
| Urinary phenyl acetate: a diagnostic test for depression? | Q52095254 | ||
| Metabolomic tissue signature in human non-alcoholic fatty liver disease identifies protective candidate metabolites | Q57568837 | ||
| Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions | Q28079432 | ||
| Pseudouridine in RNA: what, where, how, and why | Q28141248 | ||
| How to interpret hydrogen breath tests | Q28246206 | ||
| World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects | Q28300546 | ||
| Urinary metabolic signatures of human adiposity | Q29380743 | ||
| Normalization method for metabolomics data using optimal selection of multiple internal standards | Q31105641 | ||
| Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation | Q33231491 | ||
| Plant polyphenols as dietary antioxidants in human health and disease | Q33717002 | ||
| SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease | Q33759095 | ||
| The production of p-cresol sulfate and indoxyl sulfate in vegetarians versus omnivores | Q34031430 | ||
| KEGGscape: a Cytoscape app for pathway data integration | Q34078162 | ||
| Metscape 2 bioinformatics tool for the analysis and visualization of metabolomics and gene expression data. | Q34089197 | ||
| Plasma metabolomic profile in nonalcoholic fatty liver disease. | Q34180137 | ||
| Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease | Q34499017 | ||
| Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). | Q34564139 | ||
| Ribosomal RNA pseudouridines and pseudouridine synthases | Q34571025 | ||
| Plasma levels of homocysteine and cysteine increased in pediatric NAFLD and strongly correlated with severity of liver damage. | Q34685694 | ||
| The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota | Q35850620 | ||
| Global metabolomic profiling targeting childhood obesity in the Hispanic population | Q35891508 | ||
| Metabolomic Profiles of Body Mass Index in the Framingham Heart Study Reveal Distinct Cardiometabolic Phenotypes. | Q35919864 | ||
| Metabolic signatures of insulin resistance in 7,098 young adults | Q35976648 | ||
| Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. | Q36497296 | ||
| Urine glucose screening program at schools in Japan to detect children with diabetes and its outcome-incidence and clinical characteristics of childhood type 2 diabetes in Japan | Q36712902 | ||
| Microbiota and gut-liver axis: their influences on obesity and obesity-related liver disease | Q36798196 | ||
| Metabolomic profiling to dissect the role of visceral fat in cardiometabolic health | Q37023957 | ||
| Intestinal permeability in children with food allergy on specific elimination diets | Q37174259 | ||
| Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance | Q37552186 | ||
| Amino Acid Metabolism is Altered in Adolescents with Nonalcoholic Fatty Liver Disease-An Untargeted, High Resolution Metabolomics Study | Q37659179 | ||
| NMR-based metabolomic profiling of overweight adolescents: an elucidation of the effects of inter-/intraindividual differences, gender, and pubertal development. | Q37700570 | ||
| Serum metabolic profiles in overweight and obese women with and without metabolic syndrome. | Q37720807 | ||
| Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease | Q38161223 | ||
| Combined untargeted and targeted metabolomic profiling reveals urinary biomarkers for discriminating obese from normal-weight adolescents | Q38416856 | ||
| Are bidirectional associations of obesity and depression already apparent in childhood and adolescence as based on high-quality studies? A systematic review | Q38673029 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| P433 | issue | 5 | |
| P921 | main subject | metabolomics | Q12149006 |
| metabolic pathway | Q68685 | ||
| childhood obesity | Q3241451 | ||
| P577 | publication date | 2017-05-11 | |
| P1433 | published in | Nutrients | Q7070485 |
| P1476 | title | Urinary Metabolomics in Pediatric Obesity and NAFLD Identifies Metabolic Pathways/Metabolites Related to Dietary Habits and Gut-Liver Axis Perturbations | |
| P478 | volume | 9 |
| Q61807446 | Gut Microbiota-Derived Mediators as Potential Markers in Nonalcoholic Fatty Liver Disease |
| Q41552497 | Gut-Liver Axis Derangement in Non-Alcoholic Fatty Liver Disease |
| Q91090842 | Hepatic Steatosis-a complex interaction of germs, genes and grub |
| Q64259443 | Metabolomic Salivary Signature of Pediatric Obesity Related Liver Disease and Metabolic Syndrome |
| Q89510059 | Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy |
| Q92542287 | Metagenome of Gut Microbiota of Children With Nonalcoholic Fatty Liver Disease |
| Q49289627 | Nutrition and Liver Disease |
| Q92712205 | The Liver in Children With Metabolic Syndrome |
Search more.